Home
News
Social Media
Trade Signals
SEC Filings
Archives
All
/
$HALO
Investing.com
•
Investing.com
•
2 months ago
FDA approves Halozyme’s RYBREVANT FASPRO for EGFR-mutated lung cancer
$HALO
$JNJ
Very Positive